×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Featured
Want to learn more about Global Labeling 2014: Compliance in a Changing Regulatory Environment? You've come to the right site!
Program Committee
-
Steven Bass, PhD President
Bass Biopharm Consulting Group LLC, United States -
Su-Yueh Lin Sr. Labeling Consultant, Regulatory Affairs
SYL Regulatory Consulting, Taiwan -
Bruce Boulton, MSc Product Information Officer, Bureau Gastroenterology, Infection & Viral Diseases
Health Canada, Canada -
Mark Collins, PhD, MBA Principal Consultant
Opus Regulatory, United States -
Barbara J. Fanelli, MSc Associate Adjunct Professor
Temple University School of Pharmacy, United States -
A. Leander Fontaine, MD President
Pharmiceutics, LLC., United States -
Rie Matsui, RPh Senior Director, Regional Labeling Head for APAC, International Labeling
Pfizer R&D Japan G.K., Japan -
Gerrit Nijveldt, MSc Global Labeling Consultant
Opus Regulatory Inc., United States -
Barbara Lachmann, MD Sole Proprietor
Barbara Lachmann Labeling Consulting, Germany -
Megann Looker Executive Director, Head of Global Labeling
Jazz Pharmaceuticals, United Kingdom -
Julie P. Retzinger, MBA, RN Senior Director - Global Labeling and CCDS
Astellas Pharma Inc., United States -
Junko Sato, PhD Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Have an account?